Baumann, Michael

Expanding global access to radiotherapy

Atun, R., Jaffray, D. A., Barton, M. B., Bray, F., Baumann, M., Vikram, B., Hanna, T. P., Knaul, F. M., Lievens, Y., Lui, T. Y. M., et al. (2015) · The Lancet Oncology

Advances in Oncology and RadiotherapyGlobal Health and Surgery

Cited by 1,112

How much does it cost to research and develop a new drug? A systematic review and assessment

Schlander, M., Hernandez-Villafuerte, K., Cheng, C.-Y., Mestre-Ferrandiz, J., & Baumann, M. (2021) · PharmacoEconomics

Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare

Cited by 360

Expressing cytotoxic compounds in Escherichia coli Nissle 1917 for tumor-targeting therapy

Li, R., Helbig, L., Fu, J., Bian, X., Herrmann, J., Baumann, M., Stewart, A. F., Müller, R., Li, A., Zips, D., et al. (2019) · Research in Microbiology

Bacterial Cancer TherapyBacterial Genetics and Biotechnology

Cited by 73

Easing accessibility to mass spectrometry imaging using convolutional autoencoders for deriving hypoxia-associated peptide candidates from tumors

Bitto, V., Hönscheid, P., Besso, M. J., Sperling, C., Kurth, I., Baumann, M., & Brors, B. (2024) · npj Systems Biology and Applications

Mass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Cited by 6

Enhancing mass spectrometry imaging accessibility using convolutional autoencoders for deriving hypoxia-associated peptides from tumors

Bitto, V., Hönscheid, P., Besso, M. J., Sperling, C., Kurth, I., Baumann, M., & Brors, B. (2024) · npj Systems Biology and Applications

Mass Spectrometry Techniques and ApplicationsMetabolomics and Mass Spectrometry Studies

Cited by 6